Found: 73
Select item for more details and to access through your institution.
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with Cancer.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 3, p. 72, doi. 10.1159/000529128
- By:
- Publication type:
- Article
Emerging issues related to COVID-19 vaccination in patients with cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 255, doi. 10.1007/s40487-021-00157-1
- By:
- Publication type:
- Article
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
- Published in:
- Oncology & Therapy, 2020, v. 8, n. 2, p. 171, doi. 10.1007/s40487-020-00124-2
- By:
- Publication type:
- Article
Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 559, doi. 10.2147/CLEP.S400071
- By:
- Publication type:
- Article
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1386, doi. 10.3390/ijms21041386
- By:
- Publication type:
- Article
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
- Published in:
- International Journal of Oncology, 2018, v. 52, n. 2, p. 424, doi. 10.3892/ijo.2017.4212
- By:
- Publication type:
- Article
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2022, v. 23, n. 10, p. e333, doi. 10.1093/ehjci/jeac106
- By:
- Publication type:
- Article
Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183679
- By:
- Publication type:
- Article
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 242, doi. 10.1038/s41416-023-02501-w
- By:
- Publication type:
- Article
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 497, doi. 10.1007/s10549-023-07159-9
- By:
- Publication type:
- Article
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 351, doi. 10.1007/s10549-023-07116-6
- By:
- Publication type:
- Article
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 457, doi. 10.1007/s10549-022-06525-3
- By:
- Publication type:
- Article
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 107, doi. 10.1007/s10549-020-05915-9
- By:
- Publication type:
- Article
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 199, doi. 10.1007/s10549-020-05617-2
- By:
- Publication type:
- Article
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 161, doi. 10.1007/s10549-019-05453-z
- By:
- Publication type:
- Article
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 103, doi. 10.1007/s10549-019-05284-y
- By:
- Publication type:
- Article
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 607, doi. 10.1007/s10549-019-05259-z
- By:
- Publication type:
- Article
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 27, doi. 10.1007/s10549-018-5055-9
- By:
- Publication type:
- Article
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1720, doi. 10.1093/jnci/djac126
- By:
- Publication type:
- Article
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2‐positive breast cancer.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 7, p. 1, doi. 10.1111/eci.13535
- By:
- Publication type:
- Article
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.
- Published in:
- Ecancermedicalscience, 2022, v. 16, n. 1366-1414, p. 1, doi. 10.3332/ecancer.2022.1379
- By:
- Publication type:
- Article
Phosphoethanolamine and the danger of unproven drugs.
- Published in:
- Ecancermedicalscience, 2016, v. 10, n. 674-708, p. 1, doi. 10.3332/ecancer.2016.681
- By:
- Publication type:
- Article
Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25.
- Published in:
- Ecancermedicalscience, 2014, v. 8, n. 413-446, p. 1, doi. 10.3332/ecancer.2014.425
- By:
- Publication type:
- Article
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4229, doi. 10.1093/eurheartj/ehac244
- By:
- Publication type:
- Article
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 5, p. 1, doi. 10.1007/s11912-021-01038-6
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1862, doi. 10.2967/jnumed.112.119271
- By:
- Publication type:
- Article
European Society of Cardiology Core Curriculum for cardio‐oncology.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 754, doi. 10.1002/ejhf.3102
- By:
- Publication type:
- Article
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2011, v. 13, n. 1, p. 1, doi. 10.1093/eurjhf/hfq213
- By:
- Publication type:
- Article
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3075, doi. 10.1007/s00432-022-04185-w
- By:
- Publication type:
- Article
Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers.
- Published in:
- Oncologist, 2007, v. 12, n. 12, p. 1443, doi. 10.1634/theoncologist.12-12-1443
- By:
- Publication type:
- Article
Achievements in Systemic Therapies in the Pregenomic Era in Metastatic Breast Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 253, doi. 10.1634/theoncologist.12-3-253
- By:
- Publication type:
- Article
The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).
- Published in:
- Acta Oncologica, 2020, v. 59, n. 6, p. 723, doi. 10.1080/0284186X.2020.1738547
- By:
- Publication type:
- Article
Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0066848
- By:
- Publication type:
- Article
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919827714
- By:
- Publication type:
- Article
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919827714
- By:
- Publication type:
- Article
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00277-x
- By:
- Publication type:
- Article
Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.
- Published in:
- Journal of Oncology, 2012, p. 1, doi. 10.1155/2012/417673
- By:
- Publication type:
- Article